What are Ironwood Pharmaceuticals's profit margins?

Ironwood Pharmaceuticals (IRWD) runs a 99.2% gross margin and a 55.4% operating margin, with a 28.3% net margin.

Where do Ironwood Pharmaceuticals's ratios come from?

Every ratio is computed from Ironwood Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Ironwood Pharmaceuticals IRWD Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	55.4%+22.1pp	33.3%-3.1pp	36.3%+12.6pp	23.8%+7.1pp	16.7%-9.8pp
Net margin	28.3%+20.2pp	8.1%-0.3pp	8.4%+11.0pp	-2.6%+7.6pp	-10.2%-10.4pp
Efficiency
Asset turnover	0.9×+0.2×	0.8×-0.1×	0.9×0.0×	0.8×0.0×	0.8×0.0×
Liquidity
Current ratio	1.4×+0.3×	1.1×0.0×	1.1×+0.3×	0.8×-2.5×	3.3×-1.4×
Leverage
Net debt / EBITDA	-0×0.0×	-0×-0.6×	0.6×-1.0×	1.6×+3.3×	-1.7×-0.9×
Per Share
Book value per share	-$1.30+18.9%	-$1.61-8.1%	-$1.49+14.7%	-$1.74+16.0%	-$2.08-10.2%
Valuation
Market capitalization	$632.12M+457%	$548.23M+158%	$212.79M+81.2%	$117.45M-50.1%	$235.24M-66.8%
Price / earnings	6.2×—	22.8×+15.4×	7.5×—	——	——
Price / sales	1.8×+1.4×	1.9×+1.2×	0.6×+0.2×	0.4×-0.4×	0.7×-1.3×
EV / EBITDA	3.1×+2.7×	5.4×+3.1×	2.3×-0.9×	3.2×+0.6×	2.6×-4.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Ironwood Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Ironwood Pharmaceuticals's profit margins?: Ironwood Pharmaceuticals (IRWD) runs a 99.2% gross margin and a 55.4% operating margin, with a 28.3% net margin.
Where do Ironwood Pharmaceuticals's ratios come from?: Every ratio is computed from Ironwood Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.